Caris Life Sciences Inc.

NASDAQ: CAI · Real-Time Price · USD
39.75
1.63 (4.28%)
At close: Aug 22, 2025, 3:41 PM

Caris Life Sciences Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
PE Ratio
-25.3 -20.89 -22.24
PEG Ratio
-0.52 -1.31 n/a
PS Ratio
17.30 23.29 27.60
PB Ratio
-2.85 -3.32 -4.19
P/FCF Ratio
-28.11 -23.89 -21.75
P/OCF Ratio
-29.08 -25.83 -24.97
OCF/S Ratio
-0.59 -0.9 -1.11
Debt / Equity Ratio
-0.17 -0.1 -0.16
Quick Ratio
1.06 2.04 3.43
Current Ratio
1.30 2.55 3.77
Asset Turnover
1.20 0.74 0.36
Interest Coverage
-5.14 -10.11 -11.83
Return on Equity
0.11 0.16 0.19
Return on Assets
-0.82 -0.83 -0.45
Return on Invested Capital
-1.05 -0.98 -0.5
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
0.43 0.29 0.31
Net Profit Margin
-0.68 -1.12 -1.24
Pretax Profit Margin
-0.68 -1.12 -1.24
Operating Profit Margin
-0.62 -1.04 -1.22
FCF Margin
n/a n/a n/a
EBITDA Margin
-0.44 -0.85 -0.95